恒瑞医药(01276.HK)10月10日耗资6243.83万元回购90.73万股A股
Ge Long Hui·2025-10-10 08:56

Core Viewpoint - Heng Rui Medicine (01276.HK) announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1: Buyback Details - The company plans to repurchase 907,300 A-shares at a total cost of RMB 62.4383 million [1] - The buyback price per share is set between RMB 68.05 and RMB 69.66 [1]